ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1021

Transthyretin and Amyloid in Cartilage Aging and Osteoarthritis

Yukio Akasaki1, Oscar Alvarez-Garcia1, Natalia Reixach2, Joel Buxbaum2, Yukihide Iwamoto3 and Martin K. Lotz1, 1Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, 2Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, 3Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Biology and Pathology of Bone and Joint: Cartilage, Synovium and Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Deposition of amyloid is a common aging-associated phenomenon and a key factor in the pathogenesis of several aging-related diseases. Osteoarthritis is the most prevalent joint disease and aging is its major risk factor. Although amyloid deposits appear to be a prevalent in OA-affected joints, their composition and effects on cell and tissue function are unknown. Transthyretin (TTR) is an amyloidogenic protein. Point mutations in the TTR gene cause of familial amyloidotic polyneuropathy and cardiomyopathy. Wild-type TTR can also assemble into amyloid deposits and this may be facilitated by oxidation, or the presence of sulfated glycosaminoglycans. This study addressed TTR deposition in aging and OA-affected knee cartilage and effects of TTR on chondrocyte function.

Methods

Amyloid deposition in normal and OA human knee cartilage was determined by Congo-red staining and polarized light microscopy. TTR in cartilage and synovial fluid was analyzed by immunohistochemistry and western blotting. TTR gene expression in chondrocytes was studied by quantitative PCR and RNA sequencing. Effects of wild type and mutant TTR were studied in normal human chondrocyte cultures with measurements of cell viability and OA-related gene expression.

Results

There was no amyloid deposition in young normal cartilage. In contrast, 58% (7/12) of aged normal cartilage and 100% (12/12) of OA cartilage samples had Congo red staining. TTR was detectable in all OA and a majority of aged but not in young normal cartilage and predominantly located at the cartilage surfaces. TTR is not produced by chondrocytes at substantial levels and synovial fluid levels are similar in normal and OA affected knees. In chondrocytes, TTR induces cell death, the expression of proinflammatory cytokines and extracellular matrix degrading enzymes. This was observed for the amyloidogenic but not for the non-amyloidogenic TTR mutant. Effects of TTR on cell viability and gene expression are mediated by activation of TLR4 signaling and MAP kinases.

Conclusion

These findings are the first to suggest that TTR amyloid deposition may not represent an inconsequential aging-related phenomenon but contribute to cell and extracellular matrix damage in articular cartilage.


Disclosure:

Y. Akasaki,
None;

O. Alvarez-Garcia,
None;

N. Reixach,
None;

J. Buxbaum,
None;

Y. Iwamoto,
None;

M. K. Lotz,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transthyretin-and-amyloid-in-cartilage-aging-and-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology